Back to Questions
MBBS
QUESTION #10355
Question 1
HMG-CoA reductase, the rate-limiting enzyme of cholesterol biosynthesis and the pharmacological target of statin medications, catalyzes conversion of HMG-CoA to:
Correct Answer Explanation
HMG-CoA reductase catalyzes the committed, rate-limiting step of cholesterol synthesis — reduction of HMG-CoA to mevalonate; statins competitively inhibit this enzyme, reducing hepatic cholesterol synthesis and upregulating LDL receptor expression to lower circulating LDL cholesterol.
Sign in to join the conversation and share your thoughts.
Log In to Comment